Loading clinical trials...
Loading clinical trials...
Desmoid tumor is a benign neoplasm with an unpredictable course and a high rate of local recurrence if treated surgically. Therefore, over time the surgical approach has become conservative, preferring simple observation or medical therapy in case of disease progression through the use of hormonal therapy and low-dose chemotherapy. Since this neoplasm remains benign, our study aims to avoid chemotherapy in patients usually young through the use of a minimally invasive treatment such as cryotherapy.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
IRCCS Itituto Ortopedico Rizzoli
Bologna, BO, Italy
Start Date
May 20, 2021
Primary Completion Date
January 1, 2027
Completion Date
January 1, 2027
Last Updated
August 1, 2025
94
ESTIMATED participants
Cryotherapy
PROCEDURE
Lead Sponsor
Istituto Ortopedico Rizzoli
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06224283